Oral dtpa for radionuclide chelation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01) A61K 49/20 (2006.01) A61P 39/04 (2006.01)

Patent

CA 2637215

A composition for oral radionuclide chelation therapy comprises a DTPA chelate selected from Zn-DTPA and Ca-DTPA and a permeation enhancer that preferentially increases jejunal uptake of the DTPA chelate. The composition has a DTPA chelate bioavailability of at least 10% of the chelate when orally administered to a mammal.

La présente invention concerne une composition destinée à une thérapie orale par chélation de radionucléides qui contient un chélate de DTPA choisi parmi le Zn-DTPA et le Ca-DTPA ainsi qu'un adjuvant de perméation qui augmente préférentiellement l'assimilation jéjunale du chélate de DTPA. La composition présente une biodisponibilité du chélate de DTPA d'au moins 10 % de l'élément chélaté lorsqu'elle est administrée par voie orale à un mammifère.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oral dtpa for radionuclide chelation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral dtpa for radionuclide chelation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral dtpa for radionuclide chelation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2017153

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.